These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 9798264)

  • 1. Central action of glucagon.
    Morawska D; Sieklucka-Dziuba M; Kleinrok Z
    Pol J Pharmacol; 1998; 50(2):125-33. PubMed ID: 9798264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central action of insect neuropeptide, periplanetin CC-1, in mice.
    Sieklucka-Dziuba M; Morawska D; Lombarska-Sliwińska D; Konopińska D; Kleinrok Z
    Pol J Pharmacol; 1997; 49(1):43-8. PubMed ID: 9431551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central effects of endogenous and exogenous GABA.
    Czajka R
    Acta Physiol Pol; 1978; 29(3):193-205. PubMed ID: 707139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central action of adrenaline.
    Jagiełło-Wójtowicz E
    Acta Physiol Pol; 1981; 32(2):169-80. PubMed ID: 7196677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of centrally-injected glucagon-like peptide-1 on pilocarpine-induced seizures, anxiety and locomotor and exploratory activity in rat.
    Gulec G; Isbil-Buyukcoskun N; Kahveci N
    Neuropeptides; 2010 Aug; 44(4):285-91. PubMed ID: 20227110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basic central pharmacological properties of thiophosphoric acid alkaloid derivatives from Chelidonium majus L.
    Kleinrok Z; Jagiełło-Wójtowicz E; Matuszek B; Chodkowska A
    Pol J Pharmacol Pharm; 1992; 44(3):227-39. PubMed ID: 1470561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central effects of prostaglandins F2alpha and E1.
    Herman ZS; Kmieciak-Kolada K; Wolny HL; Slomińska-Zurek J; Bonczek A
    Pol J Pharmacol Pharm; 1976; 28(5):411-21. PubMed ID: 1012972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central action of sanumgerman in mice.
    Kleinrok Z; Lekim D; Jagiełło-Wójtowicz E; Chodkowska A
    Pol J Pharmacol Pharm; 1986; 38(3):299-307. PubMed ID: 3774627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-6-ketopiperidine-2-carbonyl-L-leucyl-L-proline amide as a novel thyrotropin releasing hormone analogue with improving effects on impaired central nervous systems functions.
    Oka M; Ochi Y; Furukawa K; Ito T; Miura Y; Karasawa T; Kadokawa T
    Arzneimittelforschung; 1989 Mar; 39(3):297-303. PubMed ID: 2547386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of suloctidil on the central and peripheral nervous systems].
    Nishi H; Watanabe T; Mori M
    Nihon Yakurigaku Zasshi; 1983 Sep; 82(3):191-212. PubMed ID: 6319248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central effects of octopamine administered into the lateral ventricle of rats.
    Kleinrok Z; Jagiełło-Wójtowicz E; Szkilnik E
    Acta Physiol Pol; 1979; 30(4):445-53. PubMed ID: 228526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central activity of 2-amino-4-phosphonobutyric acid (AP4).
    Zalewska A; Winnicka MM; Wiśniewski K
    Pol J Pharmacol; 1995; 47(1):9-17. PubMed ID: 7550555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solcoseryl stimulates behavioural activity of rats.
    Braszko JJ; Winnicka MM; Wiśniewski K
    Acta Physiol Hung; 1996; 84(1):63-72. PubMed ID: 8993676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of amezinium, a novel antihypotensive drug. VI. Effect on central nervous functions.
    Teschendorf HJ; Kretzschmar R; Kreiskott H; Weifenbach H
    Arzneimittelforschung; 1981; 31(9a):1580-8. PubMed ID: 7197973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [General pharmacologic studies on the analgesic flupirtine].
    Jakovlev V; Achterrath-Tuckermann U; von Schlichtegroll A; Stroman F; Thiemer K
    Arzneimittelforschung; 1985; 35(1):44-55. PubMed ID: 4039152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. General pharmacology of recombinant human tumor necrosis factor. 2nd communication: effects on central nervous system functions.
    Kurumiya S; Miura Y; Nakatsuji K; Dodo M; Hori M; Ito T
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):225-31. PubMed ID: 2334465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological properties of some xanthone derivatives.
    Rajtar G; Zółkowska D; Kleinrok Z; Marona H
    Acta Pol Pharm; 1999; 56(4):311-8. PubMed ID: 10635365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some central effects of angiotensin II. Interactions with dopaminergic transmission.
    Georgiev V; György L; Getova D; Markovska V
    Acta Physiol Pharmacol Bulg; 1985; 11(4):19-26. PubMed ID: 3012944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of lithium chloride on the rat behavior after short-term oligemic hypoxia].
    Sieklucka-Dziuba M; Gustaw K; Dziuba J; Kleinrok Z
    Ann Univ Mariae Curie Sklodowska Med; 1998; 53():59-69. PubMed ID: 10761229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.